Tripeptide compounds having hypotensive activity
US5051404A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | Sep 20, 1988 |
| Grant date | Sep 24, 1991 |
| Priority date | — |
| Expiry date | Sep 20, 2008 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/80
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Tripeptides having hypotensive activity, defined by the following general formula: EQU A--B--C--OZ (I) wherein: PA1 A represents a residue of L-pyroglutamic acid, L-proline of L-proline bearing a substituent on its amino group ##STR1## wherein R.sub.1 is an acyl with a number of carbon atoms in straight chain not higher than 9, a benzyloxycarbonyl group or an alkyloxycarbonyl group; PA1 B is an .alpha.-aminoacide residue derived from one of the natural aminoacids; PA1 C is a residue of L-tryptophan (Trp), of L-phenylalanine (Phe) or of L-tyrosine (Tyr); PA1 Z is a hydrogen atom or an alkyl group with a number of carbon atoms in straight chain not higher than 9.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.